FDA Adverse Event Malfunction Summary report: N

OMNIPOD INSULIN PUMP

MDR report key: 6140703 · Received December 2, 2016

Report

Report Number
3004464228-2016-03895
Event Type
Malfunction
Date Received
December 2, 2016
Date of Event
November 8, 2016
Report Date
November 8, 2016
Manufacturer
INSULET CORPORATION
Product Code
LZG
PMA / PMN Number
K122953
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE WAS NOT RETURNED FOR EVALUATION. IT WAS REPORTED THAT THE CANNULA HAD DISLODGED FROM THE INFUSION SITE. THIS CONDITION COULD INTERRUPT INSULIN DELIVERY AND CONTRIBUTE TO HYPERGLYCEMIA. LOT RELEASE RECORDS WERE REVIEWED AND THE PRODUCT LOT MET ALL ACCEPTANCE CRITERIA. OMNIPOD INSULIN MANAGEMENT SYSTEM ¿ USER GUIDE: MODEL: CAT45E/CAT45F, 15546-AW REV D 06/2016, USING THE POD 5 / PAGE 43-44, CHECKING YOUR BLOOD GLUCOSE 7 / PAGE 98. WARNING: CHECK OFTEN TO MAKE SURE THE POD AND SOFT CANNULA ARE SECURELY ATTACHED AND IN PLACE. A LOOSE OR DISLODGED CANNULA MAY INTERRUPT INSULIN DELIVERY. VERIFY THERE IS NO WETNESS OR SCENT OF INSULIN, WHERE AS MAY INDICATE THE CANNULA HAS DISLODGED. WARNING: BECAUSE INSULIN PODS USE ONLY RAPID-ACTING INSULIN, USERS ARE AT INCREASED RISK FOR DEVELOPING HYPERGLYCEMIA (HIGH BLOOD GLUCOSE) IF INSULIN DELIVERY IS INTERRUPTED. WARNING: IF YOU GET RESULTS BELOW 3.9 MMOL/L OR ABOVE 13.9 MMOL/L, BUT DO NOT HAVE SYMPTOMS OF HYPOGLYCEMIA OR HYPERGLYCEMIA REPEAT THE TEST. IF YOU HAVE SYMPTOMS OR CONTINUE TO GET RESULTS THAT FALL BELOW 3.9 MMOL/L OR ABOVE 13.9 MMOL/L, FOLLOW THE TREATMENT ADVICE OF YOUR HEALTHCARE PROVIDER.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE CUSTOMER'S BLOOD GLUCOSE REACHED HIGH (>500MG/DL) WHILE WEARING THE POD BETWEEN 24 AND 36 HOURS. IT WAS ALSO STATED THAT THE CANNULA WAS PROPERLY INSERTED, BUT CAME OUT HOURS LATER. (B)(6).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
792371 OMNIPOD INSULIN PUMP PUMP, INFUSION, INSULIN LZG INSULET CORPORATION 15880 L42536

Patients

Seq Age Sex Outcome Treatment
1 7 YR